Oppenheimer & Co’s Bath & Body Works BBWI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-12,264
| Closed | -$475K | – | 1578 |
|
|
2024
Q4 | $475K | Sell |
12,264
-16,271
| -57% | -$544K | 0.01% | 1080 |
|
|
2024
Q3 | $911K | Buy |
28,535
+1,231
| +5% | +$40.8K | 0.01% | 816 |
|
|
2024
Q2 | $1.07M | Buy |
27,304
+820
| +3% | +$37.6K | 0.02% | 747 |
|
|
2024
Q1 | $1.32M | Buy |
26,484
+15,842
| +149% | +$711K | 0.02% | 648 |
|
|
2023
Q4 | $459K | Sell |
10,642
-12,687
| -54% | -$428K | 0.01% | 990 |
|
|
2023
Q3 | $789K | Sell |
23,329
-3,702
| -14% | -$134K | 0.02% | 755 |
|
|
2023
Q2 | $1.01M | Buy |
27,031
+314
| +1% | +$11.5K | 0.02% | 698 |
|
|
2023
Q1 | $977K | Buy |
26,717
+15,717
| +143% | +$658K | 0.02% | 704 |
|
|
2022
Q4 | $464K | Sell |
11,000
-7,887
| -42% | -$294K | 0.01% | 932 |
|
|
2022
Q3 | $616K | Buy |
18,887
+594
| +3% | +$21K | 0.01% | 817 |
|
|
2022
Q2 | $492K | Buy |
18,293
+1,198
| +7% | +$52K | 0.01% | 925 |
|
|
2022
Q1 | $817K | Buy |
17,095
+4,252
| +33% | +$229K | 0.01% | 821 |
|
|
2021
Q4 | $896K | Buy |
12,843
+1,073
| +9% | +$76.2K | 0.02% | 814 |
|
|
2021
Q3 | $742K | Sell |
11,770
-273
| -2% | -$17.4K | 0.01% | 857 |
|
|
2021
Q2 | $702K | Buy |
12,043
+2,942
| +32% | +$159K | 0.01% | 887 |
|
|
2021
Q1 | $455K | Sell |
9,101
-151
| -2% | -$6.22K | 0.01% | 1000 |
|
|
2020
Q4 | $278K | Sell |
9,252
-1,545
| -14% | -$44.8K | 0.01% | 1113 |
|
|
2020
Q3 | $278K | Buy |
+10,797
| New | +$221K | 0.01% | 1015 |
|
|
2020
Q2 | – | Sell |
-13,279
| Closed | -$124K | – | 1261 |
|
|
2020
Q1 | $124K | Sell |
13,279
-392
| -3% | -$6.22K | ﹤0.01% | 1095 |
|
|
2019
Q4 | $200K | Sell |
13,671
-1,023
| -7% | -$14.8K | 0.01% | 1182 |
|
|
2019
Q3 | $233K | Sell |
14,694
-10,037
| -41% | -$177K | 0.01% | 1077 |
|
|
2019
Q2 | $522K | Buy |
24,731
+932
| +4% | +$18.4K | 0.01% | 790 |
|
|
2019
Q1 | $530K | Sell |
23,799
-23,332
| -50% | -$513K | 0.01% | 799 |
|
|
2018
Q4 | $979K | Buy |
47,131
+13,403
| +40% | +$338K | 0.03% | 538 |
|
|
2018
Q3 | $826K | Sell |
33,728
-11,935
| -26% | -$298K | 0.02% | 662 |
|
|
2018
Q2 | $1.36M | Buy |
45,663
+25,849
| +130% | +$746K | 0.04% | 491 |
|
|
2018
Q1 | $612K | Buy |
19,814
+4,202
| +27% | +$159K | 0.02% | 778 |
|
|
2017
Q4 | $760K | Sell |
15,612
-7,287
| -32% | -$295K | 0.02% | 708 |
|
|
2017
Q3 | $770K | Buy |
22,899
+5,415
| +31% | +$182K | 0.02% | 696 |
|
|
2017
Q2 | $762K | Buy |
17,484
+5,934
| +51% | +$243K | 0.02% | 688 |
|
|
2017
Q1 | $440K | Sell |
11,550
-1,098
| -9% | -$49.5K | 0.01% | 854 |
|
|
2016
Q4 | $674K | Sell |
12,648
-879
| -6% | -$50K | 0.02% | 694 |
|
|
2016
Q3 | $774K | Buy |
13,527
+8,673
| +179% | +$511K | 0.02% | 650 |
|
|
2016
Q2 | $263K | Buy |
4,854
+285
| +6% | +$16.7K | 0.01% | 1010 |
|
|
2016
Q1 | $324K | Buy |
4,569
+155
| +4% | +$11.1K | 0.01% | 909 |
|
|
2015
Q4 | $342K | Buy |
4,414
+1,612
| +58% | +$125K | 0.01% | 900 |
|
|
2015
Q3 | $204K | Buy |
+2,802
| New | +$194K | 0.01% | 1160 |
|
|
2015
Q2 | – | Sell |
-2,802
| Closed | -$214K | – | 1479 |
|
|
2015
Q1 | $214K | Buy |
+2,802
| New | +$202K | 0.01% | 1266 |
|
Other funds holding BBWI
Oppenheimer & Co's BBWI Position: Q1 2025 in Review
Oppenheimer & Co sold out of Bath & Body Works (BBWI) in Q1 2025, closing a stake of 12,264 shares — an estimated $475K sold.
Oppenheimer & Co first reported a position in BBWI in Q1 2015 and held it in 38 quarters. The position peaked at $1.36M in Q2 2018. 465 funds tracked by Wall St. Rank hold BBWI as of Q1 2025.
- Oppenheimer & Co reported no remaining Bath & Body Works position as of Q1 2025 after selling out during the quarter.
- Oppenheimer & Co sold 12,264 Bath & Body Works shares in Q1 2025, an estimated $475K.
- Oppenheimer & Co first reported a position in Bath & Body Works in Q1 2015 and held it in 38 quarters.
- Oppenheimer & Co's Bath & Body Works position peaked at $1.36M in Q2 2018.
- 465 funds tracked by Wall St. Rank held Bath & Body Works as of Q1 2025.
Based on Oppenheimer & Co's 13F filing for Q1 2025, filed 23 Apr 2025.